Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.
复制标题
DOI:
10.3390/molecules22010031
复制
发表时间:
2016-12-28
期刊:
影响因子:
--
通讯作者:
Rubio-Ruiz ME
中科院分区:
文献类型:
--
作者:
Ibarra-Lara L;Sánchez-Aguilar M;Sánchez-Mendoza A;Del Valle-Mondragón L;Soria-Castro E;Carreón-Torres E;Díaz-Díaz E;Vázquez-Meza H;Guarner-Lans V;Rubio-Ruiz ME
Renin-angiotensin system (RAS) activation promotes oxidative stress which increases the risk of cardiac dysfunction in metabolic syndrome (MetS) and favors local insulin resistance. Fibrates regulate RAS improving MetS, type-2 diabetes and cardiovascular diseases. We studied the effect of fenofibrate treatment on the myocardic signaling pathway of Angiotensin II (Ang II)/Angiotensin II type 1 receptor (AT1) and its relationship with oxidative stress and myocardial insulin resistance in MetS rats under heart ischemia. Control and MetS rats were assigned to the following groups: (a) sham; (b) vehicle-treated myocardial infarction (MI) (MI-V); and (c) fenofibrate-treated myocardial infarction (MI-F). Treatment with fenofibrate significantly reduced triglycerides, non-high density lipoprotein cholesterol (non-HDL-C), insulin levels and insulin resistance index (HOMA-IR) in MetS animals. MetS and MI increased Ang II concentration and AT1 expression, favored myocardial oxidative stress (high levels of malondialdehyde, overexpression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4), decreased total antioxidant capacity and diminished expression of superoxide dismutase (SOD)1, SOD2 and catalase) and inhibited expression of the insulin signaling cascade: phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PkB, also known as Akt)/Glut-4/endothelial nitric oxide synthase (eNOS). In conclusion, fenofibrate treatment favors an antioxidant environment as a consequence of a reduction of the Ang II/AT1/NOX4 signaling pathway, reestablishing the cardiac insulin signaling pathway. This might optimize cardiac metabolism and improve the vasodilator function during myocardial ischemia.
登录
查看更多内容
影响因子:
4.6
作者:
Fu F;Zhao K;Li J;Xu J;Zhang Y;Liu C;Yang W;Gao C;Li J;Zhang H;Li Y;Cui Q;Wang H;Tao L;Wang J;Quon MJ;Gao F
通讯作者:
Gao F
影响因子:
20.1
作者:
Beauloye, C;Bertrand, L;Hue, L
通讯作者:
Hue, L
影响因子:
3
作者:
Ibarra-Lara, Luz;Sanchez-Aguilar, Maria;Sanchez-Mendoza, Alicia
通讯作者:
Sanchez-Mendoza, Alicia
影响因子:
3
作者:
Ibarra-Lara, Luz;Hong, Enrique;Sanchez-Mendoza, Alicia
通讯作者:
Sanchez-Mendoza, Alicia
DOI:
10.1016/j.jtcvs.2010.08.003
发表时间:
2010-11-01
影响因子:
6
作者:
Amorim, Paulo A.;Nguyen, T. Dung;Doenst, Torsten
通讯作者:
Doenst, Torsten